Hyderabad-based Bharat Biotech's vaccine, Covaxin, received the much-awaited Emergency Use Listing (EUL) from the World Health Organization (WHO) on Wednesday, bringing relief to students, business travelers, and all those who intend to travel abroad.
The WHO decided to grant the EUL after a risk-benefit assessment of Covaxin for global use. It said in a tweet: “WHO has granted emergency use listing (EUL) to Covaxin (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of Covid-19."
"This emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic," said Dr Mariângela Simão, WHO's assistant director-general for Access to Medicines and Health Products.
This makes Covaxin the sixth vaccine to receive EUL after the Pfizer-BioNTech, AstraZeneca, Johnson & Johnson-Janssen, Moderna, and Sinopharm vaccines.
This story is from the November 04, 2021 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the November 04, 2021 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Explore last-minute options to save income tax in old regime
ELSS funds, PPF, NPS, fixed deposits are some popular options under Section 80C
Stocks of Zomato and Nykaa defy market fall
The carnage in the mid engulfed scores and smallcap space has of stocks over the last month.
Expansion to drive margins for Jindal Steel & Power
JSPL projects a capex allocation in the range of ₹7,500-10,000 crore annually for the next three-year period
Low-quality stocks trump better-quality peers in FY24
During this financial year (FY24), companies with weaker performance track record have outperformed those with stronger profiles by a huge margin, shows a study by PGIM India Mutual Fund (MF).
Goldman sees 50% upside in RIL stock by FY26
Shares of oil-to-telecom major Reliance Industries (RIL) jumped 3.6 per cent intraday to ₹2,988 on the BSE on Wednesday.
Demand pressures may hit Page Industries
The stock of Page Industries is down about 11 per cent since the start of the year on worries that weak demand, higher competitive pressures and lack of pricing power could put pressure on realisations going ahead.
RIL rally spurs market bulls
But overall breadth continues to remain weak
Primed for new AUDIENCES
Amazon Prime Video's new line-up speaks of a streaming service sure of where it is and where it wants to go
No immediate relief from HC; Kejriwal to remain in custody
The Delhi High Court on Wednesday refused to interfere with the arrest of Chief Minister Arvind Kejriwal by the Enforcement Directorate (ED) in connection with a money laundering case linked to the excise policy 'scam'.
Cong, Uddhav Sena spar over candidates in Maha
Prakash Ambedkar's VBA announces 8 candidates, hints at exiting alliance